|
Croda International Plc
nbd pc Nbd Pc, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/14%3A0-06%3A0+nbd+pc/14%3A0-06%3A0+NBD+PC/pmc08072408__pnas__2101562118__sapp-24-20-28 Average 90 stars, based on 1 article reviews
nbd pc - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Croda International Plc
phosphatidylcholine phospholipid Phosphatidylcholine Phospholipid, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/14%3A0-06%3A0+nbd+pc/16%3A0-06%3A0+NBD+PC/10__1364_slash_boe__2__002083-329-18-23 Average 90 stars, based on 1 article reviews
phosphatidylcholine phospholipid - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Croda International Plc
nbd pg Nbd Pg, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/14%3A0-06%3A0+nbd+pc/14%3A0-06%3A0+NBD+PG/pm38621120-228-23-30 Average 92 stars, based on 1 article reviews
nbd pg - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Croda International Plc
nbd lipid extraction ![]() Nbd Lipid Extraction, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/14%3A0-06%3A0+nbd+pc/14%3A0-06%3A0+NBD+PE/bio_rxiv__2025__07__03__663083-234-25-17 Average 93 stars, based on 1 article reviews
nbd lipid extraction - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Funakoshi ltd
1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine (“ 16:0-06:0 nbd pc ”, purity >99) ![]() 1 Palmitoyl 2 {6 [(7 Nitro 2 1,3 Benzoxadiazol 4 Yl)amino]Hexanoyl} Sn Glycero 3 Phosphocholine (“ 16:0 06:0 Nbd Pc ”, Purity >99), supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/14%3A0-06%3A0+nbd+pc/1+palmitoyl+2++6+++7+nitro+2+1+3+benzoxadiazol+4+yl+amino+hexanoyl++sn+glycero+3+phosphocholine++%E2%80%9C+16+0+06+0+nbd+pc++++purity++99+/pmc07393435-73-57-65 Average 90 stars, based on 1 article reviews
1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine (“ 16:0-06:0 nbd pc ”, purity >99) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
NBD PE is a fluorescently labelled lipid localized to the membrane interface. Phosphoethanolamine is the second most abundant, metabolically related aminophospholipid. It is mostly enriched in brain.
|
Buy from Supplier |
|
16:0-06:0 NBD PC acts as a potential fluorescent probe. It is used for the quantification of the soluble and membrane-bound phospholipase A2 (PLA2) activity.
|
Buy from Supplier |
|
NBD PG is a fluorescently labelled phospholipid with 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) at the headgroup of PG. PG is the second most abundant surfactant phospholipid.
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: TMC1 and TMC2 are cholesterol-dependent scramblases that regulate membrane homeostasis in auditory hair cells
doi: 10.1101/2025.07.03.663083
Figure Lengend Snippet: A. NBD-fluorescence decrease after SDT addition to POPC/PE/PS liposomes (black) or proteo-liposomes containing CmTMC1 purified in DDM/CHS (red) or FC12 (pink) or MuTMC2 purified in DDM/CHS (blue) or FC12 (light blue). B. NBD-fluorescence decrease after SDT addition to POPC/PE/PS liposomes containing 10% cholesterol (black) or proteo-liposomes containing CmTMC1 purified in DDM/CHS (red) or FC12 (pink) or MuTMC2 purified in DDM/CHS (blue) or FC12 (light blue). C. Quantification of the SDT-(yellow) and BSA-(grey) PLS activity of CmTMC1 (left) or MuTMC2 (right) purified in the conditions represented in A and B. D. NBD-fluorescence decrease after SDT addition to POPC/PE/PS liposomes (black) or CmTMC1 proteo-liposomes (red) containing increasing amounts of cholesterol (left) and quantification of CmTMC1 PLS activity in these assays (right). E. Decrease of NBD-fluorescence after SDT addition to POPC/PE/PS liposomes (black) or MuTMC2 proteo-liposomes (blue) containing increasing amounts of cholesterol (left) and quantification of MuTMC2 PLS activity in these conditions (right). H. NBD-fluorescence decrease after SDT addition to POPC liposomes (black) or proteo-liposomes containing CmTMC1 (red) or MuTMC2 (blue). I. Decrease of NBD-fluorescence after SDT addition to POPC liposomes containing 10% cholesterol (black) or proteo-liposomes containing CmTMC1 (red) or TMC2 (blue). J. Quantification of the SDT-(yellow) and BSA-based (grey) PLS activity of CmTMC1 (left) or MuTMC2 (right) of the representative data shown in H and I. K. CmTMC1 (left) or MuTMC2 (right) PLS activity, normalized by average PLS activity at 10% cholesterol, after cholesterol addition via treatment with empty mβCD (control) or mβCD/CHO complexes with increasing cholesterol amounts. Grey bars indicate PLS activity at 0% (bottom) or 10% (top) cholesterol. Mean ± SEM is shown for C, D, E, J and K. Each dot represents one independent experiment. Two (C) or one-way ANOVA (D-E, J-K) was performed to evaluate statistical significance. P values are indicated as: ns≥0.05, *<0.05, **<0.01, ***<0.001 and ****<0.0001. See also Supplemental Fig. 6A-D.
Article Snippet: For cholesterol addition experiments, POPC liposomes and proteo-liposomes were prepared as described above, except with 18:1-12:0 NBD-PE (
Techniques: Fluorescence, Liposomes, Purification, Activity Assay, Control
Journal: bioRxiv
Article Title: TMC1 and TMC2 are cholesterol-dependent scramblases that regulate membrane homeostasis in auditory hair cells
doi: 10.1101/2025.07.03.663083
Figure Lengend Snippet: NBD-fluorescence decrease after SDT addition to POPC/PE/PS liposomes (black) or MmTMC1 (red), or MmTMC2 (blue) proteo-liposomes containing 10% (A), 0% (B), or 30% cholesterol (C). D. Quantification of the MmTMC1 and MmTMC2 SDT-(yellow) and BSA-based (grey) PLS activity in the absence or presence of 10% and 30% cholesterol. Mean ± SEM is shown, and each dot represents one independent experiment. Two-way ANOVA was performed to evaluate statistical significance. E. Representative confocal images of auditory OHCs and IHCs at the middle cochlear region from P6 wild-type mice incubated in HBSS in the absence (control) or presence of benzamil, mβCD, or mβCD loaded with cholesterol (mβCD/CHO) and labeled with annexin V (magenta) and spy-555 (green) to visualize PS and F-actin, respectively. F. Quantification of background-subtracted annexin V-647 fluorescence intensity from the experimental conditions represented in E. Each dot represents the annexin V fluorescence intensity from one hair cell. Mean ± SEM is shown for n ∼ 100 OHCs and 30 IHCs from 3 tissues. One-way ANOVA was performed to evaluate statistical significance between control and treated samples. P values are indicated as: ns ≥ 0.05, ** < 0.01, and **** < 0.0001. See also Supplemental Fig. 6E-F.
Article Snippet: For cholesterol addition experiments, POPC liposomes and proteo-liposomes were prepared as described above, except with 18:1-12:0 NBD-PE (
Techniques: Fluorescence, Liposomes, Activity Assay, Incubation, Control, Labeling
Journal: bioRxiv
Article Title: TMC1 and TMC2 are cholesterol-dependent scramblases that regulate membrane homeostasis in auditory hair cells
doi: 10.1101/2025.07.03.663083
Figure Lengend Snippet: A. Localization of the equivalent residues to mouse TMC1 M412 (M507), D528 (D617) and D569 (D658) in the Caenorhabditis elegans TMC1 structure (PDB ID: 7USX). The approximate localization of the plasma membrane as calculated by the PPM web server is indicated by two parallel planes of spheres. NBD-fluorescence decrease after SDT addition to POPC/PE/PS liposomes (black) or proteo-liposomes containing wild type (gray) or mutants CmTMC1 M507K (yellow), D617N (purple) or D658N (pink) in liposomes containing 0% (B), 10% (C), or 30% (D) cholesterol. E. Quantification of the SDT-based PLS activity of wild-type CmTMC1, M507K, D617N or D658N mutants in POPC/PE/PS liposomes containing 0, 10 or 30 % cholesterol. F-H. SDT (yellow)- and BSA (grey)-based PLS activity of M507K, D617N and D658N mutants relative to wild-type CmTMC1 in proteo-liposomes containing 0% (F), 10% (G) or 30% (H) cholesterol. One-way ANOVA was performed to evaluate statistical significance between wild type and mutant TMC1 relative SDT-based activity. I-L. Representative confocal images of auditory OHCs and IHCs at the middle cochlear region from Tmc1 M412K/M412K (I) or Tmc1 D569N/D569N (K) mice incubated in HBSS without (control) or with mβCD to remove cholesterol and labeled with annexin V (magenta) or spy-555 (green) to visualize PS or F-actin. J and L. Quantification of background-subtracted annexin V-647 fluorescence intensity from the experiments showed in I or K. Mean ± SEM is shown for n∼ 100 OHCs and 30 IHCs from 3 tissues. Two-way ANOVA was performed to evaluate statistical significance between control and mβCD-treated samples in IHCs or OHCs. P values are indicated as: ns≥0.05, ** <0.01, *** <0.001, and ****<0.0001.See also Supplemental Fig. 3G-H.
Article Snippet: For cholesterol addition experiments, POPC liposomes and proteo-liposomes were prepared as described above, except with 18:1-12:0 NBD-PE (
Techniques: Clinical Proteomics, Membrane, Fluorescence, Liposomes, Activity Assay, Mutagenesis, Incubation, Control, Labeling